PRIORITY REGISTRATION

To all importers of Medicines

All authorized agents for medicine are hereby informed that priority registration will be granted for the following products.

Zidovudine 300 mg + Lamivudine 150 mg Tablets

Efavirenz Capsules / Tablets 600 mg

Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg Tablets

Lopinavir 200 mg + Ritonavir 50 mg Tablets

Abacavir Sulfate Capsules / Tablets 300 mg

Lamivudine Tablets 150 mg

Atazanavir Sulfate 300 mg + Ritonovir 100 mg Tablets

Darunavir Ethanolate 600 mg + Ritonovir 100 mg Tablets

Raltegravir Tablets 400 mg

Dolutegravir Tablets 50 mg

Tenofovir Disproxil 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg Tablets

Tenofovir Alafenamide 25 mg + Emtricitabine 200 mg + Dolutegravir 50 mg Tablets

Abacavir 60 mg + Lamivudine 30 mg Tablets

Abacavir Sulfate 120 mg + Lamivudine 60 mg Dispersible Tablets

Zidovudine 60 mg + Lamivudine 30 mg Dispersible Tablets

Lopinavir 100 mg + Ritonavir 25 mg Tablets

Efavirenz Capsules / Tablets 200 mg

Nevirapine Oral Suspension 50 mg / 5 ml - 100 ml

Dolutegravir Tablets 10 mg

Zidoviduine Syrup 5 mg / 5 ml

Lamivudine Syrup 5 mg / 5 ml

(Date: 24 November 2023)